
What “good” looks like
A consult worth booking has a named licensed clinician, a written scope, and answers you can check before you pay. National Institute on Aging questions for choosing a doctor still apply here: who you will see, how you reach them when you are ill, and which hospital they use. Longevity branding does not retire those basics.
Good clinics tolerate scrutiny. They give a license number, an itemized estimate, and a list of tests that would change a decision. They say what they will not treat. They explain how they will talk to your existing clinicians. If the scheduler becomes impatient when you ask, believe that signal.
Good preparation on your side is short and specific. Bring a medication list, allergies, prior records, and your actual goals—blood pressure, sleep, a family history, a function you want to keep. You do not need a marketing vocabulary. You need questions that distinguish a medical visit from a sales appointment.
Good outcomes of this phone call are modest. You either book a visit with a verifiable clinician and a clear price, or you walk away before the deposit. That is a successful use of the checklist. It is not a failure to “invest in yourself.”
Credentials and scope to verify
Ask for the full name, degree, and license number of the person who will take your history and make recommendations. Look them up on DocInfo or the state board that matches the visit location. If the consult is virtual, Federation of State Medical Boards telemedicine policy still ties practice to where you are sitting. A license in the clinic’s home state is not enough.
Ask who is in the room besides that clinician. A coordinator can schedule. A coach can discuss habits after a plan exists. Neither should be the person who diagnoses you or starts a drug. If the “consultation” is with a closer who later “runs it by the doctor,” you have not booked a medical visit.
Ask about scope in plain language. Will they manage a new fever? Will they refill your usual medicines? Will they only discuss prevention? There is no shame in a limited consult. There is harm in assuming a limited consult is primary care. Get the limit in writing if the fee is large.
Ask about conflicts. If the clinician also sells supplements, devices, or equity in a lab, you deserve that disclosure before you book. You can still hear their advice. You should know who profits if you say yes.
Questions to ask
Use a short list and write the answers. NIA’s doctor-choice questions plus a few longevity-specific checks cover most of the risk. You do not need twenty items if five are specific.
- Who will I see, what license do they hold, and in which state?
- What is the total cost of the consult, required tests, and the first 90 days?
- Which tests would change a medication, a referral, or a decision to wait?
- What is the emergency and after-hours plan, including the hospital you use?
- How will you coordinate with my current clinicians, and who owns incidental findings?
Add one evidence question: what would make them recommend no extra treatment. A clinician who can describe watchful waiting is safer than one who has a protocol for every lab. FTC materials on health scams are useful here; miracle language and unlawful disease-treatment claims on the website are a reason not to book at all.
If they offer video visits, ask the licensure question a second time for your state. If they offer procedures, ask who is present, what privileges they have, and what happens if you become unstable. Booking without those answers is how people buy a brand instead of a clinician.
Red flags
Refuse to book if they will not name the treating clinician or give a license number you can verify. A rotating “longevity team” is not a substitute. If the first call is a hard close on a membership, you have your answer before the medical history starts.
Required purchases are a warning. If the consult is contingent on a supplement bundle, a genetic kit, or a year-long package, you are entering a store. You can ask for a medical visit priced as a medical visit. Clinics that cannot sell that are telling you their business model.
Fear scripts are another warning. “Your biological age is a crisis” or “these labs mean you will decline unless you start today” is not informed consent. A serious clinic can explain uncertainty and give you time to talk with your primary-care clinician. Same-day hormones, infusions, or stem-cell pitches before assessment belong on the do-not-book list.
No emergency answer is sufficient reason to stay with counseling-only options—or to stay home. If they offer drugs or IVs and cannot describe 911 and a hospital, do not schedule those services. Coordination refusal (“we do not share notes”) is a related stop sign.
Cost, time, and logistics
Get the estimate in writing before you give a card. Include taxes, draw fees, shipping, and the cost of the follow-up where results are explained. Ask whether the consult fee applies to a package if you decline it. Compare cash labs with what is already indicated through your usual clinician and, when relevant, Medicare preventive coverage.
Time includes your preparation. Gather records so you do not pay to repeat last year’s work. Block time after the visit to review the plan with your primary-care clinician before you start a new drug. A same-week start is not a virtue if nobody has checked interactions.
Logistics include travel, video state rules, and cancellation. If you must fly, ask what happens if the clinician is unavailable that day. If you join from another state, confirm licensure for that day. Ask how to obtain your records if you never enroll.
Book only after the five questions have answers you can repeat: license, total cost, decision-changing tests, emergency coverage, and coordination. If any answer is missing, keep your medical home and wait. A delayed consult is cheaper than an unowned plan.
Frequently Asked Questions
References
NIA: 17 Questions to Ask When Choosing a New Doctor
https://www.nia.nih.gov/health/medical-care-and-appointments/17-questions-ask-when-choosing-new-doctorDocInfo physician license lookup
https://www.docinfo.org/FSMB: Telemedicine Key Issues and Policy
https://www.fsmb.org/advocacy/telemedicine/USPSTF recommendation topics
https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topicsFTC: Common Health Scams
https://consumer.ftc.gov/articles/common-health-scams